Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-10 10:00 am Sale |
2022-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI |
Flynn James E | 0 0.000% |
-4,695,020 (Position Closed) |
Filing History |
| 2022-11-10 4:06 pm Sale |
2022-10-31 | 13G | Aerie Pharmaceuticals, Inc. AERI |
MORGAN STANLEY MS |
384,245 0.800% |
-3,686,147 (-90.56%) |
Filing History |
| 2022-02-14 12:39 pm Sale |
2021-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI |
PFM Health Sciences, LP | 1,088,566 2.300% |
-1,725,797 (-61.32%) |
Filing History |
| 2022-02-11 4:08 pm Purchase |
2021-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI |
Flynn James E | 4,695,020 9.910% |
2,159,519 (+85.17%) |
Filing History |
| 2022-02-09 3:16 pm Sale |
2021-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI |
The Vanguard Group | 3,381,368 7.140% |
-835,703 (-19.82%) |
Filing History |
| 2022-02-09 1:28 pm Purchase |
2021-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI |
MORGAN STANLEY MS |
4,070,392 8.600% |
4,070,392 (New Position) |
Filing History |
| 2022-02-02 7:11 pm Sale |
2021-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI |
BLACKROCK INC BLK |
3,386,015 7.100% |
-506,226 (-13.01%) |
Filing History |
| 2021-08-16 5:06 pm Purchase |
2021-08-04 | 13G | Aerie Pharmaceuticals, Inc. AERI |
Flynn James E | 2,535,501 5.370% |
2,041,285 (+413.03%) |
Filing History |
| 2021-02-16 4:10 pm Purchase |
2020-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI |
PFM Health Sciences, LP | 2,814,363 6.000% |
382,864 (+15.75%) |
Filing History |
| 2021-02-10 10:30 am Sale |
2020-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI |
The Vanguard Group | 4,217,071 9.010% |
-20,420 (-0.48%) |
Filing History |
| 2021-02-09 3:14 pm Sale |
2020-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI |
HARTFORD MUTUAL FUNDS INC/CT | 0 0.000% |
-2,597,265 (Position Closed) |
Filing History |
| 2021-02-05 07:51 am Purchase |
2020-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI |
BLACKROCK INC BLK |
3,892,241 8.300% |
410,029 (+11.77%) |
Filing History |
| 2020-07-09 10:10 am Sale |
2020-06-30 | 13G | Aerie Pharmaceuticals, Inc. AERI |
WELLINGTON MANAGEMENT CO LLP | 1,194,841 2.570% |
-3,096,359 (-72.16%) |
Filing History |
| 2020-06-30 4:35 pm Sale |
2020-06-30 | 13G | Aerie Pharmaceuticals, Inc. AERI |
Flynn James E | 494,216 1.060% |
-2,037,931 (-80.48%) |
Filing History |
| 2020-06-12 3:09 pm Sale |
2020-03-31 | 13G | Aerie Pharmaceuticals, Inc. AERI |
Foresite Capital Fund II L.P. | 837,907 1.800% |
-4,686,684 (-84.83%) |
Filing History |
| 2020-06-09 10:04 am Sale |
2020-05-29 | 13G | Aerie Pharmaceuticals, Inc. AERI |
WELLINGTON MANAGEMENT CO LLP | 4,291,200 9.230% |
-2,451,497 (-36.36%) |
Filing History |